About Sreepathi Pharmaceuticals
Sreepathi Pharmaceuticals is a Healthcare company based in Hyderabad (India) founded in 1986. It manufactures APIs, intermediates, and offers custom pharmaceutical contract services. It operates on a B2B and Contract Manufacturing model. The company has 119 employees. Its Indian entity Sreepathi Pharmaceuticals Limited reported revenue of ₹74.26 Cr. Sreepathi Pharmaceuticals offers products and services including API Manufacturing, R&D Support, Specialty Chemicals Manufacturing, and Contract Manufacturing. Its focus areas include Pharmaceuticals, API Manufacturing, Custom Intermediates and Veterinary Health. Similar companies include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed similar companies have raised funding.
Company details
Sreepathi Pharmaceuticals Limited specializes in producing high-quality active pharmaceutical ingredients and intermediates, while offering contract manufacturing and RD support. Based in Hyderabad, India, they collaborate with clients RD teams to develop and deliver life-saving drugs efficiently. The company adheres to global standards and focuses on affordable medicines for human and veterinary health, serving various partners through innovative custom production.
- Headquarters Hyderabad, India
- Employees 119
- SectorsHealthcare
- Email••••••••
- Website sreepathi.com
- Legal Name Sreepathi Pharmaceuticals Limited
- Date of Incorporation 29 Dec, 1983
- Jurisdiction Telangana, India
- Annual Revenue₹74.26 Cr
FY 2025 · -17% YoY
- Net Profit₹59.7 Lakh
FY 2025 · 1% margin
- EBITDA₹6.34 Cr
FY 2025 · 9% margin
- Employee Count119
Associated legal entities of Sreepathi Pharmaceuticals
Sreepathi Pharmaceuticals operates through Sreepathi Pharmaceuticals Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Sreepathi Pharmaceuticals Limited CIN U24239TG1983PLC004356 | Active | 29 Dec 1983 | Hyderabad, Telangana | ₹74.3 Cr | 119 | 4 | View details |
Products & Services of Sreepathi Pharmaceuticals
Sreepathi Pharmaceuticals offers a comprehensive portfolio of products and services, including API Manufacturing, R&D Support, Specialty Chemicals Manufacturing, and Contract Manufacturing.
Produces high-quality active pharmaceutical ingredients for health solutions.
Assists in all phases of new product development for clients.
Creates custom-formulated specialty chemicals for various applications.
Delivers custom products based on client specifications and needs.
Board of directors of Sreepathi Pharmaceuticals Limited (Sreepathi Pharmaceuticals)
Sreepathi Pharmaceuticals Limited is the primary company behind Sreepathi Pharmaceuticals. The board of Sreepathi Pharmaceuticals Limited currently have 4 directors; the longest-serving is Srinivas Isola, appointed in 2006. 8 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Srinivas Isola DIN 00413104 | Managing Director | 09 Mar 2006 | 20 yrs 7 mo | Sreepathi Pharmaceuticals Limited |
| Shyamala Isola DIN 01962414 | Whole-time director | 08 Apr 2006 | 20 yrs 6 mo | Sreepathi Pharmaceuticals Limited |
| Satya Isola Akhil DIN 02791231 | Director | 27 Aug 2009 | 17 yrs 2 mo | Sreepathi Pharmaceuticals Limited |
| Karthik Isola Chandra DIN 07160730 | Director | 04 Jul 2018 | 8 yrs 4 mo | Sreepathi Pharmaceuticals Limited |
People of Sreepathi Pharmaceuticals
1 people are tracked at Sreepathi Pharmaceuticals (1 in leadership); the tracked headcount is 119.
| Name | Role | Group |
|---|---|---|
Ravi Chandra Kavuri | Owner | Leadership |
Complete people profiles for Sreepathi Pharmaceuticals
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Sreepathi Pharmaceuticals
Figures of Sreepathi Pharmaceuticals Limited, the primary company behind Sreepathi Pharmaceuticals, for FY 2025. Revenue was ₹74.26 Cr (-17% year on year). Net profit was ₹59.7 Lakh (1% margin). EBITDA was ₹6.34 Cr (9% margin). Revenue has grown at a compounded annual rate of -9% over three years and -3% over five years.
- ₹74.26 CrRevenue · FY 2025 · -17% YoY
- ₹59.7 LakhNet profit · 1% margin
- ₹6.34 CrEBITDA · 9% margin
- ₹3.70 CrPaid-up capital
- 119Employees (provident fund records)
- -9%Revenue CAGR, 3 years
- -3%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Sreepathi Pharmaceuticals Limited are on its company page.
Detailed financial statements for Sreepathi Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Sreepathi Pharmaceuticals
Sreepathi Pharmaceuticals has 3 listed similar companies in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| sequent.in | 2002 | Bengaluru, India | APIs are developed and manufactured for therapeutic areas. |
Detailed similar companies of Sreepathi Pharmaceuticals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Sreepathi Pharmaceuticals
Sreepathi Pharmaceuticals was founded in 1986.
Sreepathi Pharmaceuticals is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Sreepathi Pharmaceuticals has 119 employees.
The primary company behind Sreepathi Pharmaceuticals, Sreepathi Pharmaceuticals Limited, reported revenue of ₹74.26 Cr for FY 2025, down 17% year on year.
Sreepathi Pharmaceuticals Limited specializes in producing high-quality active pharmaceutical ingredients and intermediates, while offering contract manufacturing and RD support. Based in Hyderabad, India, they collaborate with clients RD teams to develop and deliver life-saving drugs efficiently. The company adheres to global standards and focuses on affordable medicines for human and veterinary health, serving various partners through innovative custom production.
Sreepathi Pharmaceuticals's top competitors include Laurus Labs, Symbiotec and SeQuent.
Sreepathi Pharmaceuticals offers API Manufacturing, R&D Support, Specialty Chemicals Manufacturing, and Contract Manufacturing.
Sreepathi Pharmaceuticals operates through Sreepathi Pharmaceuticals Limited.
The legal entities of Sreepathi Pharmaceuticals currently have 4 directors, including Srinivas Isola, Satya Isola Akhil, Karthik Isola Chandra and others.